Medgenics CEO Michael Cola receives $3.7M in 2013
Medgenics reports 2013 executive compensation
By ExecPay News
Published: March 11, 2014
Medgenics reported fiscal year 2013 executive compensation information on March 11, 2014.
In 2013, seven Medgenics executives received on average a compensation package of $1.5M, a 279% increase compared to previous year.
Average pay of disclosed executives at Medgenics
Michael F. Cola, Chief Executive Officer, received $3.7M in total. 94% of Cola's compensation, or $3.4M, was in option awards. Cola also received $93K in bonus, $133K in salary, as well as $6K in other compensation.
Garry A. Neil, Chief Scientific Officer, received a compensation package of $2.2M. 91% of the compensation package, or $2.1M, was in option awards.
John H. Leaman, Chief Financial Officer, earned $2M in 2013.
Andrew L. Pearlman, Chief Executive Officer, received $1M in 2013, which increases by 143% compared to 2012.
Clarence L. Dellio, Chief Operating Officer, earned $484K in 2013, a 74% increase compared to previous year.
Marvin R. Garovoy, Chief Medical Officer, received $454K in 2013, which increases by 1% compared to 2012.
Phyllis K. Bellin, Vice President of Administration, Misgav of MI, earned $319K in 2013.
Related executives
Andrew Pearlman
Medgenics
Chief Executive Officer
Marvin Garovoy
Medgenics
Chief Medical Officer
Clarence Dellio
Medgenics
Chief Operating Officer
Michael Cola
Medgenics
Chief Executive Officer
John Leaman
Medgenics
Chief Financial Officer
Garry Neil
Medgenics
Chief Scientific Officer
Phyllis Bellin
Medgenics
Vice President of Administration, Misgav of MI
You may also like
Source: SEC filing on March 11, 2014.